These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 544474)

  • 41. Differential susceptibility of mouse trophoblast and embryonic tissue to immune cell lysis.
    Jenkinson EJ; Billington WD
    Transplantation; 1974 Sep; 18(3):286-9. PubMed ID: 4138434
    [No Abstract]   [Full Text] [Related]  

  • 42. [Changes in the immunobiologic properties of Ehrlich ascites carcinoma under the effect of suspension from normal rat tissues. I. Heterotransplantation of Ehrlich ascites carcinoma].
    Novikov DK
    Tsitologiia; 1965; 7(3):420-3. PubMed ID: 5879870
    [No Abstract]   [Full Text] [Related]  

  • 43. Suppression of cell-mediated immunity through immune spleen cells against Ehrlich ascites tumor.
    Okubo S
    Nagoya J Med Sci; 1971 Mar; 33(4):329-40. PubMed ID: 5554418
    [No Abstract]   [Full Text] [Related]  

  • 44. [Study of the antigenic affinity between bacillus megaterium H. and ehrlich cancer cells in an anaphylaxis reaction with desensitization].
    Zatula DG; Severnikov VA
    Mikrobiol Zh; 1976; 38(2):220-4. PubMed ID: 820951
    [No Abstract]   [Full Text] [Related]  

  • 45. Augmented immunogenicity of tumor cell homogenates produced by infection with influenza virus.
    Boone CW
    Natl Cancer Inst Monogr; 1972 Dec; 35():301-7. PubMed ID: 4349150
    [No Abstract]   [Full Text] [Related]  

  • 46. Modulation of the immune response to transplantation antigens. I. The effects of immunization using adjuvants on the immune response of mice to a tumour allograft.
    Zola H
    Clin Exp Immunol; 1972 Aug; 11(4):585-93. PubMed ID: 4563711
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of cyclophosphamide on tumor cell sensitivity to the action of immunological effectors.
    Culo F; Marić M; Morović-Vergles J
    In Vivo; 1995; 9(5):439-46. PubMed ID: 8900921
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Immunogenicity of cancer-associated and cancer-specific antigens].
    del Pozo AM; Valladares Y; Alvarez-Rodríguez Y; Alvarez-Noves J
    Rev Esp Oncol; 1982; 29(4):685-700. PubMed ID: 6927369
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Possible immunological action of Vibrio cholerae neuraminidase (VCN) in tumor immunotherapy.
    Sedlacek HH; Johannsen R; Seiler FR
    Dev Biol Stand; 1977 Apr 13-15; 38():387-98. PubMed ID: 608528
    [No Abstract]   [Full Text] [Related]  

  • 50. Neuraminidase and concanavalin A in the experimental immunotherapy of cancer.
    Simmons RL; Rios A
    Johns Hopkins Med J Suppl; 1974; 3():75-84. PubMed ID: 4536589
    [No Abstract]   [Full Text] [Related]  

  • 51. MCG101-AA, a new ascites tumour in C57 mice. 4. Influence of enzyme treatment on transplantability and some in vitro characteristics.
    Hagmar B; Ryd W
    Acta Pathol Microbiol Scand A; 1975 May; 83(3):328-38. PubMed ID: 1155101
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Survival of host mice and induced resistance to transplantable ascites tumors.
    Kimura Y; Tanino T
    Jpn J Exp Med; 1966 Aug; 36(4):371-405. PubMed ID: 4291054
    [No Abstract]   [Full Text] [Related]  

  • 53. [Immunity and tumors].
    Michelazzi L
    Boll Ist Sieroter Milan; 1971; 50(3):185-91. PubMed ID: 4337946
    [No Abstract]   [Full Text] [Related]  

  • 54. Tumor therapy of neoplastic diseases with tumor cells and neuraminidase. Further experimental studies on chessboard vaccination in canine mammary tumors.
    Sedlacek HH; Hagmayer G; Seiler FR
    Cancer Immunol Immunother; 1986; 23(3):192-9. PubMed ID: 3791304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of tumor immunity in mice with antigens prepared from influenza and vesicular stomatitis virus grown in suspension culture of Ehrlich ascites cells.
    Häkkinen I; Halonen P
    J Natl Cancer Inst; 1971 Jun; 46(6):1161-7. PubMed ID: 4325929
    [No Abstract]   [Full Text] [Related]  

  • 56. Enhancement phenomenon.
    Petrányi GG
    Haematologia (Budap); 1972; 6(3):349-56. PubMed ID: 4677588
    [No Abstract]   [Full Text] [Related]  

  • 57. Hematologic changes in rats inoculated intraperitoneally with Ehrlich ascites carcinoma.
    Dabrowska B; Janik P; Radwański Z; Dux K
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):724-9. PubMed ID: 5957994
    [No Abstract]   [Full Text] [Related]  

  • 58. Antitumour effect of different corynebacterial immunostimulants in non isogenic mouse-tumour-system. (Short communication).
    Géresi M; Réthy L; Ecsy R; Gelencsér F; Padányi M; Pogány I; Bácskai L; Réthy LA
    Acta Vet Acad Sci Hung; 1981; 28(3):281-3. PubMed ID: 7258017
    [No Abstract]   [Full Text] [Related]  

  • 59. [Immunological factors (cellular and humoral) conditioning the transplantability of an "aspecific" ascites tumor (ATPC+)].
    Maltzeff N
    Lav Ist Anat Istol Patol Univ Studi Perugia; 1966; 26(2):109-25. PubMed ID: 5958970
    [No Abstract]   [Full Text] [Related]  

  • 60. Electrophoretic mobility of Ehrlich ascites carcinoma cells grown in vitro or in vivo.
    Mayhew E
    Cancer Res; 1968 Aug; 28(8):1590-5. PubMed ID: 5673572
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.